The Immune System, Inflammation, and Cancer Conference

The Immune System, Inflammation, and Cancer Conference is organized by Ausmed Education Pty Ltd and will be held from Mar 14 - 15, 2019 at ibis Brisbane, Brisbane, Queensland, Australia. This CME Conference has been approved for a maximum of 11.00 CPD Hours.

Course Overview:

Why is it that our highly crafted immune system, which forms a defensive shield to protect our body and fight infections, can switch and become destructive? The answer may lie in inflammation. As research uncovers new links between the immune system, inflammation, and diseases, such as cancer, it’s essential that we, as health professionals, remain up-to-date on advances in modern medicine. Book your place at this conference and discuss:
• Why is uncontrolled inflammation a cause for concern?
• Is inflammation linked to depression?
• Digging up the dirt on being clean - appraising the hygiene hypothesis
• The ABCs of biomarkers, biosimilars and biological agents
• CAR T-cells - driving changes in cancer treatment?
• Rethinking the critically ill patient with cancer and much, much more 

Need for Program:

More and more research continues to reveal the fascinating links between the immune system, inflammation, and diseases, such as cancer. The exciting evidence is rapidly being translated into new treatments of diseases. However, an abundance of unproven information and pseudoscience exists in this space. Therefore, it is essential that all health professionals, and particularly nurses, are provided with opportunities to access evidence-based content if health outcomes and health literacy are to remain high.

Purpose of Program:
To update health professionals on the emerging conditions associated with the immune system and its response to chronic inflammation and cancer so as to improve health outcomes.

Learning Objectives:
• Appraise various sources of information relating to inflammation so as your knowledge reflects best-available evidence
• Provide correct information and education to people in your care, enhancing patient health literacy and adherence to treatment
• Promote evidence-based preventative actions for people with health risks to enable them to avoid illness
• Identify potential triggers and initiate early interventions to prevent infections in people undergoing novel cancer therapies